iShares US Pharmaceuticals ETF
IHE
IHE
98 hedge funds and large institutions have $148M invested in iShares US Pharmaceuticals ETF in 2018 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 22 increasing their positions, 30 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
98
Holders Change
+3
Holders Change %
+3.16%
% of All Funds
2.24%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
16
Increased
22
Reduced
30
Closed
11
Calls
$3.56M
Puts
$1.96M
Net Calls
+$1.59M
Net Calls Change
-$1.75M
Top Buyers
| 1 |
1
CIBC World Market
Toronto,
Ontario, Canada
|
$4.11M |
| 2 |
2
Citadel Advisors
Miami,
Florida
|
$2.95M |
| 3 |
RWP
3
RWA Wealth Partners
Newton,
Massachusetts
|
$2.06M |
| 4 |
4
Jane Street
New York
|
$1.39M |
| 5 |
5
Bank of America
Charlotte,
North Carolina
|
$7.51M |
